Q2 FY26: Revenue up 19% YoY to Rs 179 cr, H1 PAT up 10%
AARTISURF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue from operations rose 19% YoY to Rs 179.16 cr in Q2 FY26, while H1 revenue grew 34% to Rs 395.07 cr. Q2 PAT dipped to Rs 1.63 cr from Rs 1.92 cr YoY, but H1 PAT rose 10% to Rs 4.69 cr versus Rs 4.25 cr. Operating margin held near 5.3% in H1. Auditors Gokhale and Sathe issued an unmodified review. Board also reconstituted Risk Management Committee adding Mr Parimal H Desai.
Strong topline growth of 34% in H1 but PAT margins remain thin at about 1.2 percent. Watch margin trajectory.